

The Effective Statistician - in association with PSI
Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry
The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.
Episodes
Mentioned books

Dec 12, 2024 • 17min
Sharpen The Saw
Explore the art of continuous self-improvement and the idea of 'sharpening the saw'. Discover how regular personal maintenance is essential for overall effectiveness. Learn the significance of movement, hydration, and sleep in boosting productivity. Find out how to enhance your focus and problem-solving skills by minimizing distractions. Lastly, delve into the balance of personal and professional growth, with tips on time management and the vital role of social connections for holistic well-being.

Dec 9, 2024 • 33min
Why is it important to measure exposure to digital health interventions and how to tackle the challenge
Interview with Jack Elkes
Key points:
Digital health interventions: Definition, scope, examples.
Engagement: Definition, importance, complexity.
Measurement challenges: Multidimensional data, variability, arbitrary definitions.
Mental health focus: Apps, virtual reality, stigma reduction, barriers to care.
Cluster analysis: Grouping users, multidimensional engagement measures, case studies.
Comparison to marketing: Engagement metrics, optimization, dynamic updates.
Risks and opportunities: Growing field, need for early research, potential harm.
Role of statisticians: Methodology, decentralized trials, PROs, future research.
Call to action: Explore the field, learn, engage with associations.
Digital health interventions are transforming healthcare, offering exciting opportunities and posing new challenges for statisticians and researchers alike. From defining engagement to tackling complex data with innovative methods, this field has much to explore.
I hope this episode inspires you to dive deeper into this growing area and consider how you can contribute to its evolution. If you found this discussion valuable, I encourage you to listen to the full episode and share it with your friends and colleagues who might benefit from these insights.

Dec 3, 2024 • 27min
Why Do Clinical Trials Impact the Climate Heavily and What We Can Do About It?
Interview with Annie Wright
Key points:
Environmental Impact
Carbon Footprint Drivers
Decentralized Trials
Study Design Simplification
Protocol Amendments
Waste Management
Greener Initiatives
Technology Adoption
Awareness and Collaboration
Call to Action
CO2 Calculators
Public and Private Collaboration
Clinical trials play a vital role in advancing healthcare, but their environmental impact cannot be ignored. By rethinking how we design and operate trials, we can reduce carbon emissions, streamline processes, and contribute to a greener future. Whether it’s embracing decentralized trials, simplifying study designs, or engaging in sustainability initiatives, we all have a part to play.
If this episode inspired you, share it with your friends and colleagues. Let’s spark conversations about making clinical research more sustainable and work together to create positive change. Don’t forget to listen, reflect, and take action—every step counts!

Nov 25, 2024 • 43min
Introduction to Dealing with Non-proportional Hazards
Kaspar Rufibach, an influential statistician specializing in survival analysis, dives into the complexities of non-proportional hazards. He discusses the vital differences between hazard functions and survival functions while emphasizing their clinical relevance. The conversation highlights effective communication strategies for non-statisticians and the importance of innovative data visualization. Kaspar also explores challenges in trial design and suggests alternatives to traditional effect quantification methods, all aimed at enhancing the understanding of treatment dynamics in clinical settings.

Nov 18, 2024 • 47min
How Real Leaders Help Their People Grow Professionally and As a Person
Interview with Aziza Yormizaeva and Klaus Breuer
Key points:
Leadership: Building trust, inspiring growth, and prioritizing collaboration.
Mentorship: Klaus guiding Aziza to discover her passion for statistics.
Professional Growth: Empowering team members to learn and succeed.
Authenticity: Honest communication and standing by data-driven insights.
Collaboration: Creating win-win situations for individuals and the organization.
Trust-Building: Establishing credibility through support and training.
Empowerment: Teaching others to leverage tools and make informed decisions.
Sustainable Value: Creating systems that deliver results even in your absence.
Continuous Learning: Both leaders and team members growing together.
Personal Growth: Developing not just careers, but individuals as a whole.
This episode highlights the transformative power of authentic leadership, trust, and mentorship in driving both personal and professional growth. Aziza and Klaus show us how fostering collaboration and empowering others can create lasting value for individuals and organizations alike. Their story is filled with practical lessons and inspiring insights that can help you on your own journey as a statistician, leader, or team member.

Nov 11, 2024 • 29min
Clinical Development of Gene Therapies
Interview with Oscar Segurado, MD PhD
Key points:
Gene Therapy Uniqueness: Differences from traditional drug development
Safety & Dosing: Single-dose approach, safety considerations
Statisticians' Role: Essential contributions in planning and analysis
Guest Background: Oscar’s expertise in academia, med tech, biopharma, Humira development
Clinical Development: Phases from trials to commercialization
Rare Disease Focus: Hemophilia A, spinal muscular atrophy
Challenges & Opportunities: Unique clinical and statistical challenges
Future of Medicine: Insights into advancements in gene therapy
Oscar’s expertise sheds light on the unique challenges and groundbreaking possibilities in this field, highlighting the critical role that statisticians and data scientists play in advancing these therapies.
If you found this episode insightful, I encourage you to listen in full and share it with colleagues, friends, or anyone interested in the future of healthcare. Let’s spread the word on how statistical expertise is driving the next frontier in medicine—tune in, learn, and pass it on!

Nov 4, 2024 • 43min
Statistical Topics in Gene Therapy
Avery McIntosh, a statistician at Pfizer specializing in gene therapy, and Oleksandr Sverdlov from Novartis, focusing on neuroscience, share their insights into the innovative world of gene therapy. They discuss the evolution and breakthroughs in the field, like CRISPR technology, while addressing the ethical challenges of clinical trials. Their experiences highlight the important role statisticians play in navigating regulatory demands and advancing treatment solutions. Listeners will appreciate the blend of technical expertise and compelling storytelling.

Oct 28, 2024 • 36min
Clinical Development Plans
In this engaging discussion, Carrie Li, a physician and statistician with over 13 years in the pharmaceutical sector, shares her insights on Clinical Development Plans (CDPs). She highlights the importance of early decision-making and cross-functional collaboration among clinical, commercial, and regulatory teams. Carrie elaborates on the differences between big pharma and startups, adaptive design strategies, and regulatory engagement with the FDA and EMA. Listeners will gain practical tips on balancing scientific rigor with business goals to advance drug development.

Oct 21, 2024 • 45min
The Most Important Things You Need to Know About AI And ML
Pietro Mascheroni, a physicist at Beringer Ingelheim specializing in machine learning and AI, dives into the transformative power of large language models (LLMs) in pharmaceutical research. He discusses their practical applications like document retrieval and data exploration. Pietro emphasizes the necessity of human oversight to ensure accuracy, while explaining how LLMs enhance team communication and collaboration. He highlights the challenges of validating AI models and the evolving capabilities of these technologies, reinforcing their potential to streamline workflows.

Oct 14, 2024 • 41min
Can Statisticians Contribute to Moving Out of The Statistics Function?
Interview with Swarna Khare
Key points:
Expanding Careers: Statisticians moving beyond traditional statistics roles.
Transferable Skills: Data interpretation, strategic thinking, communication.
Career Transition: Swarna’s journey from statistician to strategic roles.
Broader Impact: Using statistical skills in non-technical positions.
Practical Advice: How statisticians can leverage their expertise.
Opportunities: New career paths and roles outside statistics.
Actionable Insights: Steps for statisticians to broaden their horizons.
In this episode, Swarna’s journey shows how statisticians can successfully move beyond the traditional boundaries of their roles and make a broader impact in various industries. If you're looking to take your skills to the next level and explore new career opportunities, this episode is full of valuable insights and practical advice.


